Announcement on Relocation of Company Office Premises
Filed with SSE · · 1 page · Chinese
Ningbo Menovo Pharmaceutical Co., Ltd. on 6ix
Earlier from Ningbo Menovo Pharmaceutical
- Announcement on the Holding Subsidiary Re-certified as High-tech Enterprise
- Announcement on Expected Increase in Performance for 2025
- Announcement on the Subsidiary Re-certified as High-tech Enterprise
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Adempas Riociguat Tablets
Later from Ningbo Menovo Pharmaceutical
- Announcement on Not Revising the Downward Conversion Price of "Menovo Convertible Bonds"
- Announcement on the Implementation of Repurchase and Cancellation of Equity Incentive Restricted Stocks
- Announcement on Selection of Products of the Wholly-owned Subsidiary for Continuation Procurement Under National Procurement Scheme After Agreement Expiry
- Indicative Announcement on the Completion of Cancellation of Repurchased Shares and Passive Change in Equity of Shareholder with Over 5% Shares Reaching an Integral Multiple of 1%
- Announcement on Abnormal Fluctuation of Convertible Bond Trading and Risk Warning in Stock Trading
Follow Ningbo Menovo Pharmaceutical into a list and get an email when it puts out news.
Follow Ningbo Menovo Pharmaceutical